A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers
Manufactured using solid-phase peptide synthesis (SPPS), this peptide is produced under controlled conditions to ensure structural precision, reproducibility, and analytical reliability
Even with a high BMI, starting low is safer and gives the best chance for the patient to continue treatment
Repeat in 2 to 4 days if required or as recommended by a veterinarian
The compounded version offers a more accessible alternative to brand-name medications, prepared by specialized pharmacies rather than pharmaceutical giants
Sermorelin If you are currently using sermorelin or other hormone-related therapies, your provider should review them before determining whether PT-141 is appropriate